Furthermore, analysis of The Cancer Genome Atlas (TCGA) data sets revealed patients with higher FAM83A expression had poorer overall survival and disease-free survival (P<0.001, P<0.001; Figure 1b), suggesting that FAM83A may have a critical role in pancreatic cancer progression. This evidence concerns the gene SACK1A and pancreatic neoplasm.